Showing results (451-460 of 495) with videos related to

Sort By:
Pageof 50
Frontiers in Immunology|January 25, 2024
Adjuvant immunotherapy improves recurrence-free and overall survival following surgical resection for intermediate/advanced hepatocellular carcinoma a multicenter propensity matching analysisXiao Xu, Ming-Da Wang, Jia-Hao Xu, et al.
European Journal of Radiology|September 20, 2025
Potential values of uEXPLORER total-body PET/CT in nasopharyngeal carcinoma: dynamic imaging and kinetic parametersYing-Ying Hu, Zhen-Chong Yang, Li-Ping Liang, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 14, 2019
Histologic pattern is better correlated with clinical outcomes than biochemical classification in patients with drug-induced liver injuryQiu-Ju Tian, Xin-Yan Zhao, Yan Wang, et al.
Hepatology International|August 12, 2009
Patterns of managing chronic hepatitis B treatment-related drug resistance: a survey of physicians in Mainland China, South Korea, Taiwan, and ThailandSiwaporn Chainuvati, Jun Cheng, Jin Lin Hou, et al.
Alimentary Pharmacology & Therapeutics|September 4, 2020
Very low probability of significant liver inflammation in chronic hepatitis B patients with low ALT levels in the absence of liver fibrosisMilan J Sonneveld, Willem P Brouwer, Bettina E Hansen, et al.
Frontiers in Medicine|June 12, 2023
Comparison of oral sodium phosphate tablets and polyethylene glycol lavage solution for colonoscopy preparation: a systematic review and meta-analysis of randomized clinical trialsLi Yao-Dong, Wang Yi-Ping, Mai Gang, et al.
Hepatology International|July 24, 2015
Two-year results of a randomized, phase III comparative trial of telbivudine versus lamivudine in Chinese patientsJi-Dong Jia, Jin-Lin Hou, You-Kuan Yin, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|May 26, 2007
[The degree of HBV suppression with 24 week telbivudine- or lamivudine-treatment in hepatitis B patients predicts the efficacy of the treatment at week 52]Ji-dong Jia, Jin-lin Hou, You-kuan Yin, et al.
World Journal of Gastroenterology|March 31, 2018
Daclatasvir plus asunaprevir in treatment-naïve patients with hepatitis C virus genotype 1b infectionLai Wei, Fu-Sheng Wang, Ming-Xiang Zhang, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 3, 2021
Postoperative morbidity adversely impacts long-term oncologic prognosis following hepatectomy for hepatocellular carcinoma: A multicenter observational studyLin-Qiang Li, Lei Liang, Li-Yang Sun, et al.
Pageof 50